Indonesia Healthcare Market is expected to Reach USD 32.5 Billion by 2022: Ken Research - PowerPoint PPT Presentation


PPT – Indonesia Healthcare Market is expected to Reach USD 32.5 Billion by 2022: Ken Research PowerPoint presentation | free to download - id: 895b7a-ZjEyZ


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation

Indonesia Healthcare Market is expected to Reach USD 32.5 Billion by 2022: Ken Research


The healthcare market has increased on the account of increasing healthcare facilities, innovation in pharmaceutical manufacturers and clinical laboratory services and expansion of pharmacy retail chains across the country. For more information on the research report, refer to below link: – PowerPoint PPT presentation

Number of Views:12


Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Indonesia Healthcare Market is expected to Reach USD 32.5 Billion by 2022: Ken Research

Indonesia Healthcare Market is expected to Reach
USD 32.5 Billion by 2022 Ken Research
Indonesia Healthcare market segment by hospital,
pharmaceutical, pharmacy retail, clinical
laboratory and medical devices, hospital market
segment (by public private hospitals, by
general specialty hospitals and by region),
pharmaceutical market segment (by therapeutic
segment, by domestic international players, by
generic patented drug, by OTC prescription
drugs, by domestic sales exports and by
region), pharmacy retail market segment (by
pharmacies drugstores and by region), clinical
laboratory market segment (by type of clinical
laboratory, by type of private
independent laboratory, by type of customer, by
payer, by type of test and by region) and medical
device market segment (by type of medical device,
by type of medical consumables, by end user and
by procurement), competitive landscape of major
players in the Indonesia hospital,
pharmaceutical, pharmacy retail, clinical
laboratory and medical devices market and
covering company profile of major Hospitals
(Mitra Keluarga Karyasehat Tbk Pt, Siloam
Hospitals, PT Sejahteraraya Anugrahjaya, Sarana
Meditama, Rumah Sakit Pondok Indah, Surya
Husadha, Jakarta Eye Center), pharmaceutical
companies (PT Kalbe Farma, PT Sanbe Farma, PT
SOHO Global Health, PT Dexa Medica, PT Pharos, PT
Kimia Farma, PT Tempo Scan Pacific, PT Merck),
Pharmacy Retail (Guardian Pharmacy, Kimia Farma,
Apotek K-24, A S Watsons, Century Healthcare),
Diagnostic Laboratories (Prodia, Kimia Farma
Diagnostika, Pramita, Cito, BioMedika, Parahita),
Medical Devices Companies (GE Healthcare
Indonesia, Siemens Indonesia, Philips Indonesia,
PT Mensa Binasukses, PT Transmedic Indonesia)
  • The healthcare market in Indonesia was majorly
    impacted by the implementation of JKN (The
    Indonesian National Health Insurance) as the
    demand for affordable/ primary healthcare
    services, generic medicines and import of medical
    devices increased.
  • Indonesia pharmaceutical market is dominated by
    domestic players such as PT Kalbe Farma, PT Sanbe
    Farma, PT SOHO Global Health and others. The
    Indonesia Medical device market is almost
    entirely import driven due to limited
    manufacturing capabilities in Indonesia.
  • Siloam Hospitals has the largest hospital network
    in the country. Public sector hospital has the
    larger share in terms of number of hospitals in
  • Indonesia Healthcare market will be facilitated
    by the rising number of healthcare providers
    coupled with elevating prevalence of chronic
    diseases such as diabetes, HIV, Tuberculosis and
    others. More than 35,000 new beds are likely to
    be added in Indonesia by 2020.

  • Moreover, due to the entry of new participants
    into the private hospital market and expansion of
    existing ones, the country is expected to achieve
    1.5 beds per 1,000 people by 2019.
  • Single specialty or multi-specialty hospitals in
    the country are planning to invest in advanced
    medical devices to provide tertiary or super
    specialty treatment to the patients. For
    instance, Mandaya Hospital expects to see sharp
    revenue growth 30.0 y-o-y rise in 2018 as the
    hospital will invest in new equipment that should
    boost demand.
  • In the long term, the pharmaceutical industry
    will witness an increase in demand for nutrition
    and micronutrient supplements due to growing
    prevalence of lifestyle diseases such as obesity
    and malnutrition. Apart from manufacturing
    generic and patented drugs, pharmaceutical
    companies will shift focus to other niche
    segments such as combined dosages, novel drug
    delivery areas. Further,

  • Indonesia pharmaceutical market is expected to
    grow in future with increasing ageing population,
    growth in health care expenditure and increasing
    lifestyle related diseases.
  • The major pharmacy chains in the country are
    expected to launch various mobile applications
    and online retail services thus increasing
    accessibility and convenience of home delivery
    and online payment facility. The online stores
    will adopt omni-channel mode of expansion with
    strong expansion of brick and mortar stores in
    order to support online sales by reducing
    delivery time and improving accessibility.
  • The clinical laboratory market is expected to
    increase 1.5 times by 2022 supported by higher
    growth in esoteric tests segment. Further, the
    industry will witness a rising trend towards
    precision medicine also known as personalized
    medicine. Growth in the availability of testing
    equipment that can be operated locally and that
    does not require free-standing clinical
    laboratories and advancements in

self-testing kits that can be operated by
customers themselves can result in a decrease in
the volume of tests at laboratories. Increased
focus on research and development for
pharmaceutical products, medical devices and
laboratory services coupled with elevating
prevalence of chronic and lifestyle diseases will
propel the Indonesia healthcare market revenue in
future. Ken Research in its latest study,
Indonesia Healthcare Market Outlook to 2022 - by
Hospitals, Clinical Laboratories, Pharmaceutical,
Pharmacy Chains, Medical Device Segment,
suggested that demand for healthcare services in
the market will continue to grow in Indonesia
owing to favorable government regulations for FDI
inflows, rising prominence of health tech
startups, increased focus on biopharmaceuticals
and nutrition and dietary supplements.
  • Key Topics Covered in the Report
  • Pharmacy Retail Industry Trends Indonesia
  • Vitamin and Mineral Supplements Indonesia
  • Kalbe Farma Market Share Indonesia
  • Indonesia Healthcare Statistics
  • Polyclinic Market Indonesia
  • Number of Clinical Labs Prodia
  • Number of Pharmacies Indonesia
  • Medical Devices Market Indonesia
  • Diabetes Prevalence Indonesia
  • Number of Drugstore Indonesia
  • Healthcare Market Size Indonesia
  • Indonesia Healthcare Market Future
  • Pharmaceutical Market Indonesia
  • Indonesia Pharmacy Retail Market Future
  • Hospital Market Future Trends Indonesia
  • Indonesia Medical Devices Market Future

  • Indonesia Number of General Hospitals
  • Indonesia Pharmaceutical Market Future
  • Value Chain Clinical Laboratory market Indonesia
  • For more information on the research report,
    refer to below link
  • https//
  • Related Reports by Ken Research
  • https//
  • https//

  • https//
  • Contact
  • Ken Research
  • Ankur Gupta, Head Marketing Communications
  • 91-124-4230204